We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Patent Board Institutes Inter Partes Review Of Allergan Patent

Mealey's (August 30, 2018, 12:38 PM EDT) -- ALEXANDRIA, Va. — An Amneal Pharmaceuticals LLC challenge to a patent covering the dermatologic drug dapsone will proceed before the Patent Trial and Appeal Board, which instituted inter partes review on...
To view the full article, register now.